Literature DB >> 3072921

Antimicrobial susceptibility patterns of Nocardia asteroides.

R J Wallace1, L C Steele, G Sumter, J M Smith.   

Abstract

Testing of the susceptibility to 12 antimicrobial agents, including beta-lactams, aminoglycosides, ciprofloxacin, and erythromycin, was performed by broth microdilution on 78 consecutive clinical isolates of Nocardia asteroides. Surprisingly, a limited number of patterns of susceptibility were identified that included all drug classes, with 95% of isolates exhibiting one of five patterns. One group (17%) exhibited resistance to the broad-spectrum cephalosporins, one group (18%) was susceptible to both ampicillin and erythromycin, one group (17%) was susceptible to ampicillin and carbenicillin but intermediate in susceptibility to imipenem, and the most common group (35%) was resistant to ampicillin but susceptible to the broad-spectrum cephalosporins and imipenem. The most active parenteral agents were amikacin (95%), imipenem (88%), ceftriaxone (82%), and cefotaxime (82%), while the most active oral agents were the sulfonamides (100%), minocycline (100%), and ampicillin (40%). Additional studies are needed to determine whether differences in beta-lactamases relate to varying beta-lactam resistance and whether taxonomic differences that correlate with the different susceptibility groups can be identified.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072921      PMCID: PMC176016          DOI: 10.1128/AAC.32.12.1776

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA.

Authors:  A W BAUER; J C SHERRIS
Journal:  Chemotherapia (Basel)       Date:  1964

2.  In vitro susceptibility of Nocardia asteroides to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Disk diffusion susceptibility testing of Nocardia species.

Authors:  R J Wallace; E J Septimus; D M Musher; R R Martin
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

4.  Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia.

Authors:  R J Wallace; P Vance; A Weissfeld; R R Martin
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

5.  Numerical analysis of the taxonomy of Nocardiae and Rhodococci.

Authors:  M Tsukamura
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

6.  Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.

Authors:  M E Gombert
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

7.  Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy.

Authors:  R J Wallace; K Wiss; R Curvey; P H Vance; J Steadham
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

8.  Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.

Authors:  L Gutmann; F W Goldstein; M D Kitzis; B Hautefort; C Darmon; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

9.  In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.

Authors:  M H Cynamon; G S Palmer
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

10.  Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro.

Authors:  M C Bach; L D Sabath; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

View more
  89 in total

1.  Identification of medically relevant Nocardia species with an abbreviated battery of tests.

Authors:  Deanna L Kiska; Karen Hicks; David J Pettit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Separate Nocardia infections in a patient with chronic granulomatous disease.

Authors:  A Gaafar; M J Unzaga; R Cisterna; M V Leal; V Bustamante; J M Triapu; J A Crespo
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis.

Authors:  R W Wilson; V A Steingrube; B A Brown; Z Blacklock; K C Jost; A McNabb; W D Colby; J R Biehle; J L Gibson; R J Wallace
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 4.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

5.  Catheter-associated Nocardia higoensis bacteremia in a child with acute lymphocytic leukemia.

Authors:  Michael E Watson; Michele M Estabrook; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

6.  Successful treatment of a disseminated Nocardia brasiliensis infection.

Authors:  L C Smeets; M A van Agtmael; E R van der Vorm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

7.  Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species.

Authors:  Verónica Rodríguez-Nava; Andrée Couble; Gregory Devulder; Jean-Pierre Flandrois; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Nocardia cyriacigeorgica septicemia.

Authors:  Sameer Elsayed; Angela Kealey; Carla S Coffin; Ron Read; David Megran; Kunyan Zhang
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

9.  Organisms designated as Nocardia asteroides drug pattern type VI are members of the species Nocardia cyriacigeorgica.

Authors:  Patricia S Conville; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

10.  In vitro antimicrobial susceptibilities of Nocardia species.

Authors:  N Khardori; R Shawar; R Gupta; B Rosenbaum; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.